Document Text (Pages 151-160) Back to Document

In Silico Drug Design of Biofilm Inhibitors of Staphylococcus epidermidis

by Al-mulla, Aymen Faraoun, MS

Page 151

dehydrogenase. International Research Journal of Biological
Sciences, 2:812.
Hira, V., Sluijter, M., Estevao, S., Horst-Kreft, D., Ott, A., Groot, R.

(2007). Clinical and molecular epidemiologic characteristics of
coagulase-negative staphylococcal blood stream infections in
intensive care neonates. Pediatric Infectious Disease Journal,
Hoeltje, H., Sippl, W., Rognan, D. and Folkers, G.(2003). Molecular

Modeling, Basics Principles and Applications. John Wiley & Sons,
Chichester, U.K.
Holt, J., Krieg, N., Sneath, P., Staley, J. and Williams, S. (1994).

Bergey's Manual of Determinative Bacteriology. 9th ed. Williams
and Wilkins. Baltimore, Maryland, USA.
Horswill, A. , Stoodley, P., Stewart, P. and Parsek, M. (2007). The

effect of the chemical, biological, and physical environment on
quorum sensing in structured microbial communities. Analytical and
Bioanalytical Chemistry, 387: 371-380.
Huebner, J. and Goldmann, D. (1999). Coagulase-negative

staphylococci: Role as pathogens. Annual Review of Medicine,
Humphrey B., Dickson M. and Marshall K. (1979). Physiochemical

and in situ observations on the adhesion of gliding bacteria to
surfaces. Archives of Microbiology, 120:231238.
Imperi, F., Massai, F., Pillai, C., Longo, F., Zennaro, E., Rampioni,

G. (2012). New life for an old drug: the anthelmintic drug
niclosamide inhibits pseudomonas aeruginosa quorum sensing.
Antimicrobial Agents and Chemotherapy, 57:996-1005.

Page 152

Irwin, J. and Shoichet, B. (2005). ZINC a free database of
commercially available compounds for virtual screening. Journal of
Chemical Information and Modeling, 45:177182.
Jacobsen, A. (2013). The effect of antimicrobial peptides on

bacterial biofilms. MSc thesis, Roskilde University, Denmark.
Jain, A. (2004). Virtual screening in lead discovery and

optimization. Current Opinion in Drug Discovery & Development,
7: 396403.
Jarvis, B., Lach, V. and Wood, J. (1977). Evalution of the spiral plate

maker for the enumeration of Microorganism Food. Journal of
Applied Bacteriology, 43:149 157.
Källberg, M., Wang, H., Wang, S., Peng, J., Wang, Z., Lu, H.

(2012).Template-based protein structure modeling using the
RaptorX web server. Nature Protocols, 7:15111522.
Kapetanovic, I. (2008). Computer-aided drug discovery and

development (caddd): In silico chemico-biological approach.
Chemico-Biological Interactions, 171: 165176.
Kasam, V. (2009). In silico drug discovery on computational Grids

for finding novel drugs against neglected diseases. PhD Thesis.
University of Bonn, Germany.
Keyser, P., Elofsson, M., Rosell, S. and Wolf-Watz, H. (2008).

Virulence blockers as alternatives to antibiotics: type III secretion
inhibitors against Gram-negative bacteria. Journal of Internal
Medicine, 264:17-29.

Page 153

Khudhur, I. (2013). Investigating the Ability of some Bacterial
Species to Produce Slime Layer. Rafidain Journal of Science, 24:36-
Kies, S., Otto, M., Vuong, C. and Gotz, F. (2001). Identification of

the sigB operon in Staphylococcus epidermidis: Construction and
characterization of a sigB deletion mutant. Infection and Immunity,
69: 7933-7936.
Kitchen, D., Decornez, H., Furr, J. and Bajorath, J. (2004). Docking

and scoring in virtual screening for drug discovery: methods and
applications. Nature Reviews Drug Discovery, 3:935949.
Knobloch, J., Jager, S., Horstkotte, M., Rohde, H. and Mack, D.

(2004). RsbU dependent regulation of Staphylococcus epidermidis
biofilm formation is mediated via the alternative sigma factor sigma
(B) by repression of the negative regulator gene icaR. Infection and
Immunity, 72: 3838-3848.
Koes, D. and Camacho, C. (2012). ZINCPharmer: pharmacophore

search of the ZINC database. Nucleic Acids Research, 40:W409-
Koh, J. (2003). Making virtual screening a reality. Proceedings of

the National Academy of Science U S A, 100: 69026903.
Kong, K., Vuong, C. and Otto, M. (2006). Staphylococcus quorum

sensing in biofilm formation and infection. International Journal of
Medical Microbiology, 296:133-139.
Köppen, H. (2009). Virtual screening - what does it give us? .

Current Opinion in Drug Discovery & Development, 12:397407.

Page 154

Kubinyi, H.(1999). Chance favors the prepared mind from

serendipity to rational drug design. Journal of Receptors and Signal
Transduction Research, 19: 1539.
Kuntz, I. (1992). Structure-based strategies for drug design and

discovery. Science, 257:10781082.
Kuntz, I., Blaney, J., Oatley, S., Langridge, R. and Ferrin, T. (1982).

A geometric approach to macromolecule-ligand interactions.
Journal of Molecular Biology, 161: 269288.
Lalani, T., Kanafani, Z., Chu, V., Moore, L., Corey, G., Pappas, P.

)8002(. Prosthetic valve endocarditis due to coagulase-negative
staphylococci: findings from the International Collaboration on
Endocarditis Merged Database. European Journal of Clinical
Microbiology and Infectious Diseases, 25:365-368.
Leach, A. and Gillet, V. (2003). An Introduction to

Chemoinformatics. Kluwer Academic publishers, Netherlands.
Lengauer, T. (2001). Bioinformatics from Genome to Drugs.

Wiley- VCH, Weinheim, Germany.
Li, M., Villaruz, A., Vadyvaloo, V., Sturdevant, D. and Otto, M.

(2008). Al-2-dependent gene regulation in Staphylococcus
epidermidis. BMC Microbiology, 8: 4-12.
Liu, Y., Manna, A., Pan, C., Kriksunov, I., Thiel, D., Cheung, A.

(2006). Structural and function analysis of the global regulatory
protein SarA from Staphylococcus aureus.
National Academy of Sciences USA, 103:23922397.
Proceedings of the

Lӧnn-Stensrud, J., Landin, M., Benneche, M., Petersen, F. and

Scheie, A. (2009). Furanones, potential agents for preventing

Page 155

Staphylococcus epidermidis biofilm infections? Journal of
Antimicrobial Chemotherapy, 63:309316.
Mack, D., Davies, A., Harris, L., Rohde, H., Horstkotte, M. and

Knobloch, J. (2007). Microbial interactions in Staphylococcus
epidermidis biofilms. Analytical and Bioanalytical Chemistry,
Madsen, U., Krogsgaard-Larsen, P. and Liljefors, T. (2002).

Textbook of Drug Design and Discovery. Taylor and Francis.
Washington, USA.
Mah, T. and O’Toole, G. (2001). Mechanisms of biofilm resistance

to antimicrobial agents. Trends in Microbiology, 9:3439.
Mandal ,S., Moudgil, M. and Mandal, S. (2009). Rational drug

design. European Journal of Pharmacology, 625:90-100.
Markus, H., Seifert, J. and Bernd, K. (2007). Virtual highthroughput
screening of molecular databases. Journal of Current
Opnion in Drug Discovery and Development, 10: 298-307.
Matthiesen, R. (2010). Bioinformatics Methods in Clinical

Research. Humana Press, New York, USA.
McInnes, C.(2007).Virtual screening strategies in drug discovery.

Current Opinion in Chemical Biology, 11: 494502.
McKevitt, A., Bjornson, G., Mauracher, C. and Scheifele, D. (1990).

Amino acid sequence of a delta like toxin from Staphylococcus
epidermidis. Infection and Immunity, 58:1473-1475.
Moitessier, N., Englebienne, P., Lee, D., Lawandi, J. and Corbeil, C.

(2008). Towards the development of universal, fast and highly

Page 156

accurate docking/scoring methods: a long way to go. British Journal
of Pharmacology, 153: S7S26.
Muegge, I. and Martin, Y. (1999). A general and fast scoring

function for protein-ligand interactions: a simplified potential
approach. Journal of Medicinal Chemistry, 42:791804.
Mueller, F. and Lieberman, S. (1970). Fitting a Double-Exponential

Curve to Observed Salicylate Concentrations in Blood. Journal of
Pharmaceutical Sciences, 59:514-517.
Nadell, C., Xavier, J., Levin, S. and Foster, K. (2008). The evolution

of quorum sensing in bacterial biofilms. PLoS Biology, 6: 171-179.
Noori, H. and Spanagel, R. (2013). In silico pharmacology: drug

design and discovery’s gate to the future. In Silico Pharmacology,
O'Gara, J. (2007). Ica and beyond: biofilm mechanisms and

regulation in Staphylococcus epidermidis and Staphylococcus
aureus. FEMS Microbiology Letters, 270:179-188.
Otto, M. (2008). Staphylococcal biofilms. Current Topics in

Microbiology and Immunology, 322: 207-228.
Otto, M. (2009). Staphylococcus epidermidis - the 'accidental'

pathogen. Nature Reviews Microbiology, 7: 555-567.
Otto, M., Sussmuth, R., Jung, G. and Gotz, F. (1998). Structure of

the pheromone peptide of the Staphylococcus epidermidis agr
system. FEBS Letters, 424:89-94.
Parsek, M. and Greenberg, E. (2005). Sociomicrobiology: the

connections between quorum sensing and biofilms. Trends in
Microbiology, 13:27-33.

Page 157

Peach, M. and Nicklaus, M. (2009). Combining docking with
pharmacophore filtering for improved virtual screening. Journal of
Cheminformatics, 1:1-6.
Plewczynski, D., Philips, A., von Grotthuss, M., Rychlewski, L. and

Ginalski K. (2010). HarmonyDOCK: the structural analysis of poses
in protein-ligand docking. Journal of Computational Biology, 18: 1-
Rao, V. and Srinivas, K. (2011). Modern drug discovery process: An

In silico approach. Journal of Bioinformatics and Sequence
Analysis, 2:89-94.
Reddy, A., Pati, S., Kumar, P., Pradeep, H. and Sastry,

G.(2007).Virtual screening in drug discovery a computational
perspective. Current Protein and Peptide Science, 8: 329351.
Rester, U. (2008). From virtuality to reality - virtual screening in

lead discovery and lead optimization: a medicinal chemistry
perspective. Current Opinion in Drug Discovery and Development,
11: 559568.
Ribeiro, M., Monteiro, F. and Ferraz, M. (2012). Infection of

orthopedic implants with emphasis on bacterial adhesion process
and techniques used in studying bacterial-material interactions.
Biomatter, 2:176194.
Roberts, C., Anderson, K., Murphy, E., Projan, S., Mounts, W.,

Hurlburt, B. (2006). Characterizing the effect of the Staphylococcus
aureus virulence factor regulator, SarA, on log-phase mRNA halflives.
Journal of Bacteriology, 188:25932603.

Page 158

Rogers, K., Fey, P. and Rupp, M. (2009). Coagulase-Negative
Staphylococcal Infections. Infectious Disease Clinics of North
America, 23:73-98.
Rohde, H., Mack, D., Christner, M., Burdelski, C., Franke, G. and

Knobloch, J. (2006). Pathogenesis of staphylococcal device related
infections: from basic science to new diagnostic, therapeutic and
prophylactic approaches. Reviews in Medical Microbiology, 17: 45
Roos, K. (1997). Central nervous system infections and pregnancy.

Neurologist, 3:241-247.
Rossney, A., English, L. and Keane, C. (1990). Coagulase testing

compared with commercial kits for routinely identifying
Staphylococcus aureus. Journal of Clinical Pathology, 43:246-252.
Rost, B. (1999). Twilight Zone of Protein Sequence Alignments.

Protein Engineering, 12:85-94.
Rumack, B. (2002). Acetaminophen Hepatotoxicity: the first 35

years. Journal of Toxicology-Clinical Toxicology, 40:3-20.
Rupp, M., Fey, P., Heilmann, C. and Gotz, F. (2001).

Characterisation of the importance of Staphylococcus epidermidis
autolysin and polysaccharide intercellular adhesin in the
pathogenesis of intravascular catheter-associated infection in a rat
model. Journal of Infectious Diseases, 183:1038-1042.
Saha, S., Islam, M., Shilpi, J. and Hasan, S. (2013). Inhibition of

VEGF: a novel mechanism to control angiogenesis by Withania
somnifera’s key metabolite Withaferin A. In Silico Pharmacology,

Page 159

Saha, S. and Raghava, G. (2007). BTXpred: prediction of bacterial
toxins. In Silico Biology, 7:405-412.
Schoenfelder, S., Lange, C., Eckart, M., Hennig, S., Kozytska, S.,

and Ziebuhr, W. (2010). Success through diversity how
Staphylococcus epidermidis establishes as a nosocomial pathogen.
International Journal of Medical Microbiology, 300: 380386.
Schoonover, A. (2009). Development of bacterial oxidative stress

assays: towards using fluorescence methods. MSc Thesis, Western
Carolina University, USA.
Shahrooei, M. (2010). Identification of Potential Targets for

Vaccination Against Staphylococcus epidermidis Biofilms. PhD
thesis, Katholieke University, Leuven, Belgium.
Slack , M. and Wheldon, D. (1978). simple and safe volumetric

alternative to the method of Miles & Micra, and Irwin for counting
viable bacteria. Microbiology, 11: 541-544.
Sloot, N., Thomas, M., Marre, R. and Gatermann, S. (1992).

Purification and characterisation of elastase from Staphylococcus
epidermidis. Journal of Medical Microbiology, 37:201-205.
Stewart, P. and Franklin, M. (2008). Physiological heterogeneity in

biofilms. Nature Reviews Microbiology, 6:199-210.
Stewart, P., Mukherjee, P. and Ghannoum, M. (2004). Biofilm

antimicrobial resistance. In: “M., Ghannoum, G., O’Toole (Eds.),
Microbial Biofilms”. ASM Press, Washington, D.C., pp. 250–268.
Subramaniam, S., Mehrotra, M. and Gupta, D.(2008). Virtual high

throughput screening (vhts) - a perspective. Bioinformation, 3: 14

Page 160

Sushko, I., Novotarskyi, S., Körner, R., Pandey, A. , Cherkasov, A.,
Li, J. (2010). Applicability domains for classification problems:
benchmarking of distance to models for AMES mutagenicity set.
Journal of Chemical Information and Modeling, 50:2094-2111.
Sutherland I. (2001). The biofilm matrix: an immobilized but

dynamic microbial environment. Trends in Microbiology, 9:222
Tao, J., Fan, C., Gao, S., Wang, H., Liang, G. and Zhang, Q. (2006).

Depression of biofilm formation and antibiotic resistance by sarA
disruption in Staphylococcus epidermidis. World Journal of
Gastroenterology, 12: 4009-4013.
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., and

Kumar, S. (2011). MEGA5: Molecular Evolutionary Genetics
Analysis using Maximum Likelihood, Evolutionary Distance, and
Maximum Parsimony Methods. Molecular Biology and Evolution
28: 2731-2739.
Teufel, P. and Gotz, F. (1993). Characterisation of an extracellular

metalloprotease with elastase activity from Staphylococcus
epidermidis. Journal of Bacteriology, 175:4218-4224.
Tomlinson, A., Simmons, P., Seal, D. and McFadyen, A. (2000).

Salicylate inhibition of Acanthamoeba attachment to contact lenses.
Opthalmology, 107:112117.
Tormo, M., Marti, M., Valle, J., Manna, A., Cheung, A., Lasa, I.

(2005a). SarA is an essential positive regulator of Staphylococcus
epidermidis biofilm development. Journal of Bacteriology,

© 2009 All Rights Reserved.